An interventional study of Topical use and laparoscopic repair of inguinal hernia in Pain, sponsored by Western Galilee Hospital-Nahariya. Status unknown at 1 site in Israel. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2016-07-11.
Sponsored by Western Galilee Hospital-Nahariya · Not applicable, Interventional, and Treatment
Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.
At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs
Western Galilee Hospital-Nahariya is the lead sponsor of 87 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Topical use of Ropivacaine
Drug: Topical use · Other: laparoscopic repair of inguinal hernia · Other: laparoscopic bariatric surgery
Topical use of placebo
Drug: Topical use · Other: laparoscopic repair of inguinal hernia · Other: laparoscopic bariatric surgery
Topical use of Ropivacaine in laparoscopic surgery
Also known as: Ropivacaine, Placebo
intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia
intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery
Pain scale as measured by pain scale questionnaire
post operative pain intensity will be assisted by VAS(visual analog pain scale) scale at fixed times after surgery
Time frame: 1 Week
Reducing use of narcotics according to nurse records
patients will be treated by standard analgetic protocol, the records of analgetic drugs will be collected during patients hospitalization
Time frame: 1 Week
This study is status unknown, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Western Galilee Hospital-Nahariya